期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
PTGS2 identified as a biomarker of glucocorticoid-induced osteonecrosis of the femoral head and an enhancer of osteogenesis
1
作者 Qingyu Zhang Shun Lu +2 位作者 Dongsheng Zhou Jun Dong fanxiao liu 《Genes & Diseases》 SCIE CSCD 2023年第1期14-17,共4页
Due to the use of more adjuvant therapies and the increasing prevalence of associated diseases,nontraumatic osteonecrosis of the femoral head(ONFH)has become a substantial worldwide health issue;while glucocorticoid a... Due to the use of more adjuvant therapies and the increasing prevalence of associated diseases,nontraumatic osteonecrosis of the femoral head(ONFH)has become a substantial worldwide health issue;while glucocorticoid administration was the highest-ranked risk factor,with a proportion ranging from 26.35 to 55.75%.1 Albeit with similar radiological features,glucocorticoid-induced ONFH(GONFH)manifested a greater probability for advance-tolate-stage(post-collapse)lesions in comparison with its non-glucocorticoid-induced counterparts.i1 Therefore,an accurate and timely diagnosis of osteonecrosis following glucocorticoid therapy is of great significance to initiate nonoperative treatment regimens or joint-preserving procedures,slow disease progression,and defer or avert joint arthroplasty. 展开更多
关键词 GLUCOCORTICOID DIAGNOSIS OPERATIVE
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部